https://allmind.ai/earnings/event/1703194
NeoGenomics Q4 2016 Neogenomics Inc Earnings Call | AllMind AI Earnings | AllMind AI
Feb 22, 2017 - Full transcript of NeoGenomics earnings call on February 22, 2017. Q4 2016 Neogenomics Inc Earnings Call. Read the complete earnings call transcript with audio...
earnings callneogenomicsincai
https://www.leicabiosystems.com/en-se/knowledge-pathway/authors/julie-broccardo/
Julie Broccardo, NeoGenomics Laboratories
Explore Julie Broccardo's insights on pathology operations. Learn how the Aperio GT 450 improves throughput and reduces QC time in digital pathology workflows.
juliebroccardoneogenomicslaboratories
https://spotijob.rolle.ch/uk/elements-1/neogenomics-europe-sa-en-liquidation
NeoGenomics Europe SA en liquidation
la societe a pour but principal la fourniture d essais cliniques en laboratoire a des fins de recherche et tous autres actes legaux afin de faciliter le but de...
neogenomicseuropesaliquidation
https://www.quiverquant.com/stock/NEO/insiders/
NEO | NeoGenomics, Inc. Insider Trading
See the most recent insider transactions for NeoGenomics, Inc. (NEO). View the total shares held, purchased, and sold by insiders.
insider tradingneoinc
https://scholars.mssm.edu/en/clippings/neogenomics-plummets-43-in-2025-underperforming-84-of-the-market/
NeoGenomics plummets 43% in 2025, underperforming 84% of the market - Icahn School of Medicine at...
the marketneogenomicsplummetsschoolmedicine
https://leetoday.com/value-of-fort-myers-based-medical-equipment-and-services-company-neogenomics-inc-neonaq-rose-6-9-in-week-ending-aug-6/
Value of Fort Myers-based Medical Equipment and Services company Neogenomics Inc. (NEO:NAQ) rose...
Oct 28, 2025 - Motus GI Holdings Inc. (MOTS:NAQ) was the highest Medical Equipment and Services company headquartered in Florida on Aug. 3.
equipment and servicesfort myersvaluebasedmedical
https://www.biospace.com/neogenomics-agrees-to-acquire-trapelo-health?s=79
NeoGenomics Agrees to Acquire Trapelo Health - BioSpace
Mar 24, 2021 - NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today...
neogenomicsagreesacquirehealthbiospace